Active Pharmaceutical Ingredients (APIs)

APIs are the chemical compounds responsible for the primary therapeutic effects of a drug. Today, the global API market exceeds $200 billion annually and continues to grow rapidly due to increasing population demands and advancements in pharmaceutical technologies.

The importation and distribution of APIs are subject to strict international regulations. Organizations such as the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency) maintain rigorous oversight of the manufacturing, transportation, and storage of APIs. In Iran, the Food and Drug Administration (IFDA) also mandates compliance with GMP standards and submission of complete quality analysis documentation for API imports.

Due to import restrictions and sanction-related financial barriers, sourcing high-quality APIs is one of the major concerns for pharmaceutical companies in Iran. Raman Shimi Fanavar has established strong partnerships with reputable suppliers across India, China, Europe, and other regions to provide reliable and cost-effective API procurement solutions.

As a young yet highly specialized company, we operate with agility and a deep understanding of the Iranian pharmaceutical market. We are capable of sourcing APIs quickly, precisely, and at competitive prices. We also offer expert consultation in supplier selection, quality documentation review, and regulatory coordination with the Iranian Food and Drug Administration.

We procure and import the required APIs for our clients from IFDA-approved sources, aligned with quality standards and budget expectations. For more information, free consultation, or to place an order, please visit our Contact us page.